Abstract
Background
One-anastomosis gastric bypass (OAGB) is gaining more attention in patients with severe obesity and recently is used for patients with body mass index (BMI) < 35 kg/m2. In this 5-year single center experience we aim to report our outcomes of using OAGB for patients with BMI < 35 kg/m2.
Methods
This is a retrospective analysis of prospectively collected data recorded in to our national obesity registry database. Variables including age, sex, weight, BMI, any associated disease, blood levels of metabolic markers, nutrients, and vitamins before and after surgery were extracted and analyzed.
Results
173 patients with mean age and BMI of 41 ± 10 years and 33 ± 1 kg/m2 underwent OAGB and at least one of the obesity-associated medical problems was found in 88 (50.5%) of them preoperatively. The mean duration of surgery and length of hospital stay were 60.7 ± 7.4 min and 1.3 ± 1.4 days. 78% and 70% of patients had available data at 24 and 60 months, respectively. The mean BMI was 23.9 ± 2.2 kg/m2 1 year after surgery and each year after that till 5 years was 24 ± 2, 24.4 ± 2.6, 25.1 ± 2.7, and 25.5 ± 2.7 kg/m2. Significant improvement in levels of fasting blood glucose, lipid profile, and liver enzymes were observed.
Conclusion
OAGB for BMI < 35 kg/m2 has significant effects in weight loss, helps remit diabetes and hypertension in the majority of cases, improves lipid profile, and has no increased burden of postoperative problems or deficiency in nutritional factors rather than what is known and predictable.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00464-024-10928-2/MediaObjects/464_2024_10928_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00464-024-10928-2/MediaObjects/464_2024_10928_Fig2_HTML.png)
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author through email address on reasonable request.
References
Aminian A, Chang J, Brethauer SA, Kim JJ (2018) ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30–35 kg/m2). Surg Obes Relat Dis 14:1071–1087. https://doi.org/10.1016/j.soard.2018.05.025
Busetto L, Dixon J, De Luca M, Shikora S, Pories W, Angrisani L (2014) Bariatric surgery in class i obesity: a position statement from the international federation for the surgery of obesity and metabolic disorders (IFSO). Obes Surg 24:487–519
Vitiello A, Angrisani L, Santonicola A, Iovino P, Pilone V, Forestieri P (2019) Bariatric surgery versus lifestyle intervention in class I obesity: 7–10-year results of a retrospective study. World J Surg 43:758–762. https://doi.org/10.1007/s00268-018-4847-8
Shahmiri SS, Parmar C, Yang W, Lainas P, Pouwels S, DavarpanahJazi AH et al (2023) Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons. BMC Surg 23:1–13. https://doi.org/10.1186/s12893-023-02175-4
Sharaiha RZ, Shikora S, White KP, Macedo G, Toouli J, Kow L (2023) Summarizing consensus guidelines on obesity management: a joint, multidisciplinary venture of the International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO) and World Gastroenterology Organisation (WGO). J Clin Gastroenterol 57(10):967–976. https://doi.org/10.1097/MCG.0000000000001916
Salminen P, Kow L, Aminian A, Kaplan LM, Nimeri A, Prager G et al (2024) IFSO consensus on definitions and clinical practice guidelines for obesity management—an international Delphi study. Obes Surg 34:30–42. https://doi.org/10.1007/s11695-023-06913-8
De Luca M, Angrisani L, Himpens J, Busetto L, Scopinaro N, Weiner R et al (2016) Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg 26:1659–1696. https://doi.org/10.1007/s11695-016-2271-4
Ghiassi S, Nimeri A, Aleassa EM, Grover BT, Eisenberg D, Carter J (2023) American Society for Metabolic and Bariatric Surgery position statement on one-anastomosis gastric bypass. Surg Obes Relat Dis 20(4):319–335. https://doi.org/10.1016/j.soard.2023.11.003
De Luca M, Piatto G, Merola G, Himpens J, Chevallier JM, Carbajo MA et al (2021) IFSO update position statement on One Anastomosis Gastric Bypass (OAGB). Obes Surg 31:3251–3278. https://doi.org/10.1007/s11695-021-05413-x
Brown WA, Shikora SA, Liem R, Holland J, Campbell AB, Sprinkhuizen SM et al (2022) Seventh IFSO global registry report. https://www.ifso.com/pdf/ifso-7th-registry-report-2022.pdf
Li X, Hu X, Fu C, Han L, **e M, Ouyang S (2023) Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity: a meta-analysis and systematic review. Obes Surg 33:611–622
Mahawar KK, Himpens J, Shikora SA, Chevallier JM, Lakdawala M, De Luca M et al (2018) The first consensus statement on one anastomosis/mini gastric bypass (OAGB/MGB) using a modified Delphi approach. Obes Surg Obesity Surgery 28:303–312
Parmar CD, Mahawar KK (2018) One anastomosis (mini) gastric bypass is now an established bariatric procedure: a systematic review of 12,807 patients. Obes Surg 28(9):2956–2967. https://doi.org/10.1007/s11695-018-3382-x
Ramos AC, Chevallier J-M, Mahawar K, Brown W, Kow L, White KP et al (2020) IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) consensus conference statement on one-anastomosis gastric bypass (OAGB-MGB): results of a modified Delphi study. Obes Surg 30:1625–1634. https://doi.org/10.1007/s11695-020-04519-y
Parmar CD, Zakeri R, Mahawar K (2020) A systematic review of one anastomosis/mini gastric bypass as a metabolic operation for patients with body mass index ≤ 35 kg/m2. Obes Surg Obesity Surg 30:725–735
Tasdighi E, Barzin M, Mahawar KK, Hosseinpanah F, Ebadinejad A, Taraghikhah N et al (2022) Effect of biliopancreatic limb length on weight loss, postoperative complications, and remission of comorbidities in one anastomosis gastric bypass: a systematic review and meta-analysis. Obes Surg 32:892–903. https://doi.org/10.1007/s11695-021-05848-2
Boyle M, Mahawar K (2020) One anastomosis gastric bypass performed with a 150-cm biliopancreatic limb delivers weight loss outcomes similar to those with a 200-cm biliopancreatic limb at 18–24 months. Obes Surg 30:1258–1264. https://doi.org/10.1007/s11695-019-04359-5
Pizza F, Lucido FS, D’Antonio D, Tolone S, Gambardella C, Dell’Isola C et al (2020) Biliopancreatic limb length in one anastomosis gastric bypass: which is the best? Obes Surg 30:3685–3694
Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV et al (2023) 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg 33:3–14. https://doi.org/10.1007/s11695-022-06332-1
Kermansaravi M, Shahmiri SS, Khalaj A, Jalali SM, Amini M, Alamdari NM et al (2022) The first web-based Iranian national obesity and metabolic surgery database (INOSD). Obes Surg 32:2083–2086. https://doi.org/10.1007/s11695-022-06014-y
Lee WJ, Wang W, Lee YC, Te HM, Ser KH, Chen JC (2008) Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg 12:945–952
Kermansaravi M, Valizadeh R, Shahsavan M, Adel Maleknia S, Eghbali F, Pazouki A et al (2024) Metabolic and bariatric surgery in patients with class I obesity; a two-year follow-up. BMC Surg 24:1–7
Kim MJ, Hur KY (2014) Short-term outcomes of laparoscopic single anastomosis gastric bypass (LSAGB) for the treatment of type 2 diabetes in lower BMI (<30 kg/m2) patients. Obes Surg 24:1044–1051
Kim Z, Hur KY (2011) Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg 35:631–636
Kular KS, Manchanda N, Cheema GK (2016) Seven years of mini-gastric bypass in type II diabetes patients with a body mass index <35 kg/m2. Obes Surg 26:1457–1462
Osman Abouzeid TA, Ain Shoka AA, Abd Elsamee Atia KS (2019) From diabetes remedy to diabetes remission; could single-anastomosis gastric bypass be a safe bridge to reach target in non-obese patients? Asian J Surg 42:307–313. https://doi.org/10.1016/j.asjsur.2018.04.002
Amirbeigi A, Abbaslou F, Talebpour M, Soroush A, Elyasinia F, Zabihi Mahmoudabadi H et al (2022) One anastomosis gastric bypass surgery in Type2 diabetes patients with body mass index < 35 kg/m2: a multi-center retrospective cohort study. Ann Med Surg 79:104102. https://doi.org/10.1016/j.amsu.2022.104102
Navarrete Aulestia S, Leyba JL, Navarrete Llopis S, Pulgar V (2019) One anastomosis gastric bypass/minigastric bypass in patients with BMI < 35 kg/m2 and type 2 diabetes mellitus: preliminary report. Obes Surg 29:3987–3991
García-Caballero M, Valle M, Martínez-Moreno JM, Miralles F, Toval JA, Mata JM et al (2012) Resolution of diabetes mellitus and metabolic syndrome in normal weight 24–29 BMI patients with one anastomosis gastric bypass. Nutr Hosp 27:623–631
Vázquez Pelcastre R, Zenteno Martínez DC, Arana Reyes JC, Méndez Vivas WR, Ríos Ayala EV, Briseño DB (2021) One-anastomosis gastric bypass in patients with BMI < 30 kg/m2 and diabetes mellitus type 2. Nutr Hosp 38:971–977
Keleidari B, Mahmoudieh M, Shahabi S, Sheikhbahaei E, Rezaei M, Sayadi M et al (2020) Reversing one-anastomosis gastric bypass surgery due to severe and refractory hypoalbuminemia. World J Surg 44:1200–1208
Lee WJ, Chong K, Lin YH, Wei JH, Chen SC (2014) Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg 24:1552–1562
Davarpanah Jazi AH, Shahabi S, Sheikhbahaei E, Tolone S, El SM, Kabir A et al (2023) A systematic review and meta-analysis on GERD after OAGB: rate, treatments, and success. Expert Rev Gastroenterol Hepatol. https://doi.org/10.1080/17474124.2023.2296992
Kermansaravi M, Abbas A, Pishgahroudsari M, Pazouki A (2021) Short-term outcomes of the conversion of one anastomosis gastric bypass to Roux-en-Y gastric bypass in symptomatic reflux patients without revising the size of the gastric pouch. J Minim Access Surg 17:318–321
Kermansaravi M, Parmar C, Chiappetta S, Shahabi S, Abbass A, Abbas SI et al (2022) Patient selection in one anastomosis/mini gastric bypass—an expert modified Delphi consensus. Obes Surg 32:2512–2524
Funding
This experimental study was not funded in any way.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Shahab Shahabi Shahmiri, Shiva Safari, Erfan Sheikhbahaei, Mohammad Fathi, Delaram Moosavi, Seyed Nooredin Daryabari, Abdolreza Pazouki, Chetan D. Parmar, and Mohammad Kermansaravi: have no conflicts of interest or financial ties to disclose.
Ethical approval
N/A (retrospective analysis from a database registry).
Consent for publication
N/A.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shahabi Shahmiri, S., Safari, S., Sheikhbahaei, E. et al. Midterm outcomes of one anastomosis gastric bypass for patients with BMI < 35 kg/m2 from a large single center. Surg Endosc 38, 3940–3947 (2024). https://doi.org/10.1007/s00464-024-10928-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-024-10928-2